Experts explore data quality in cancer care

 

The Peer Exchange convened by The American Journal of Managed Care brought together payers and providers to hear their views on the value proposition of quality measures in oncology.

Leaders from Priority Health, Aetna, Humana, Cigna, Harvard Medical School and Dana-Farber Cancer Institute identified key quality measures in oncology and agreed that stakeholders have yet to reach consensus on the most critical and relevant measures to improve quality of patient care.

Read more below:

Around the web

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Mark Isenberg, executive vice president of Zotec Partners, discusses key developments that will reshape the specialty this year.